Canadian-led study shows amnioinfusion does not reduce risk of meconium aspiration syndrome
5th Sep 2005, 14:30 GMT
An international randomized trial, funded by the Canadian Institutes of Health Research (CIHR), has revealed that amnioinfusion, the infusion of saline into the uterus, does not reduce the risk of meconium aspiration syndrome (MAS), as previously believed.
Latest news from EurekAlert! - Breaking News:
- Scientists capture nanoscale images with short and intense X-ray laser
- Mayo researchers offer evidence people with psoriasis greater risk for developing heart disease
- Mayo Clinic information about accelerated aging among people with rheumatoid arthritis
- ESSP launches project on the effects of global environmental change on human health
- Health inequalities are a growing problem worldwide
- HIV/AIDS linked to extensively drug resistant TB
- Higher death rate for heart attack patients with additional non-cardiac conditions
- Hormone linked to brain's cravings for food and other energy sources
- Key to acute lung injury lies in Ang2 protein
- Propane fuel cell passes muster at Exit Glacier Nature Center